Evaluation of Plasma Alcohol Concentration in Patients Receiving Paclitaxel or Docetaxel

The purpose of this study is to evaluate plasma alcohol concentration in patients receiving Paclitaxel or Docetaxel infusion.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Tumors Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Institut Curie

Paris, 75005, France

About this study

In this study, there is no experimental treatment, or experimental care.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Chemotherapy with docetaxel or paclitaxel on an every 3-week schedule.
Patient with bitherapy are eligible only if the taxane is the first infusion.
All type of tumor.
Age>18 years old.
Signed written informed consent.

Exclusion criteria

Patient under 18.
Patient with bitherapy, if docetaxel or paclitaxel is not administered first.
Patient deprived of liberty.

Treatment and study plan

Blood sampling

Other

Other: Blood sampling 10mL of peripherical blood will be collected specially for the study. It's an additional blood sampling compare to the normal follow up of the patient.

Primary outcomes

Evaluation of plasma alcohol

Time frame: One year

Measure of the plasma alcohol level before and after a taxane-based therapy (docetaxel or paclitaxel)

Sponsors and collaborators

Lead sponsor

Institut Curie

Other

Registry information

Official study title

Prospective Evaluation of Plasma Alcohol Concentration in Patients Receiving Paclitaxel or Docetaxel Infusion

Acronym: ALCOOTAX

Important dates

Study start: 2011
Primary completion: 2012
Study completion: 2012
First posted: Oct 7, 2011
Registry last updated: Apr 24, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed